|Fastest Growing Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The Saliva Collection and Diagnosis Market is projected to register a CAGR of 10% during the forecast period (2022-2027).
Amidst COVID-19, the Saliva collection and diagnosis market is expected to grow owing to the rising cases of infectious disease among the people. The increase in consumer-based DNA testing is projected to create lucrative opportunities for the saliva collection and diagnosis market. The increasing rate of COVID-19 disease spread led to the demand for quick and efficient diagnoses to get the infection treatment. According to World Health Organization (WHO), in 2022, the number of new COVID-19 cases increased by 5% across the globe. The market players took this opportunity to expand their product line and gain a significant market share by providing diagnostic tools. For Instance, In April 2021, Chembio Diagnostics, Inc. announced the launch of an FDA emergency use authorization- approved, in license rapid Point of Care testing (POCT ) for COVID-19 for use in the decentralized and traditional testing settings.
The increasing prevalence of infectious diseases among people across the globe is assumed to be one of the major driving factors for market growth. According to the World Health Organization (WHO), in 2021, 60 % of the global population will be suffering from infectious diseases. Also, the report states that Infectious diseases kill over 17 million people a year, which warns of a global crisis. The rise in the number of infectious cases led to the demand for safe and effective diagnostic systems. Hence, saliva collection and diagnosis play a major role as a non-invasive diagnostic method for screening patients. Also, the increase in the product approvals of saliva collection and diagnostic equipment is also a contributing factor to boosting the market's growth. For Instance, in 2021, Hologic Inc.'s HOLX optima SARS- COV-2 molecular diagnostic test got (Common Era) CE marking by the European Union for its use with a saliva sample.
Therefore increase in the incidence of infectious diseases across the globe led to the increase in demand for saliva collection and diagnosis, resulting in market growth.
Scope of the Report
As per the scope of this report, the Saliva Collection and Diagnosis Market is a transport and collection system used for collecting clinical specimens for diagnosis purposes. The Saliva Collection and Diagnosis Market is segmented by Site of Collection (Parotid Gland Collection, Submandibular Collection, Minor Salivary Glands Collection), By Application (Diagnostic Laboratories, Forensics, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in USD million for the above segments.
|By Site of Collection|
|Parotid Gland Collection|
|Minor Salivary Glands Collection|
Key Market Trends
The Diagnostic Laboratories Segment is Expected to Hold a Major Market Share in the Saliva Collection and Diagnosis Market Market
The sudden outbreak of COVID-19 increased the demand for saliva collection and diagnosis due to the increased infectious cases of COVID-19 disease across the world.
The diagnostic laboratories segment is expected to drive the market's growth due to the increasing usage of saliva collection and diagnosis. Owing to the non-invasive methods of diagnosis, the saliva collection and diagnostic market is expected to grow in the forecast period. Also, the rising prevalence of chronic diseases such as cancer among people led to the increasing usage of non-invasive screening methods in diagnostic laboratories. The Saliva collection and diagnosis is widely used in cancer diagnosis in diagnostic laboratories owing to the accuracy and painless procedure. According to the report published by the National Institute of Health (NIH), in 2020, Saliva tests have over 90% accuracy in detecting oral cancer. In 2022, the American Cancer Society estimated that about 54,00 new cases of the oral cavity or oropharyngeal cancer were in the United States. The increase in such chronic diseases led to an increase in the usage of saliva collection and diagnosis in diagnostic laboratories, which further propels the market's growth.
To understand key trends, Download Sample Report
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period.
The United States is likely to command the global market owing to the technological innovations in the diagnostic devices used for disease testing. The increasing prevalence of chronic diseases in the United States contributes to the growing demand for Saliva collection and diagnosis products. According to the National Health Council, in 2020, around 157 million in the United States reported chronic diseases. Moreover, the increase in the growth of the pharmaceutical and biotechnology industry in the region of the united states favors the growth of the saliva collection and diagnosis market. According to the Binder Dijker Otte (BDO) USA Reports, in 2020, companies listed on the biotechnology index (NBI) saw a growth in revenue to 1.049 billion in 2020. Average research and development spending increased by 16% in 2020 to 284.25 million USD in the United States pharmaceutical industry. Thus, the increasing research and development activities in the United States region provide lucrative opportunities for the saliva collection and diagnosis market growth. Also, the presence of major market players along with the skilled personnel to handle the equipment is expected to drive the market growth in this region.
To understand geography trends, Download Sample Report
The Saliva Collection and Diagnosis Market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Thermo Fisher Scientific, Neogen Corporation, Abbott, Sarstedt AG & Co.KG, Autogen Inc, Oasis Diagnostics, Porex, Salimetrics, LLC, Takara Bio, Inc, Arcis Bio, Orasure Technologies, and others.
In December 2021, Cotipharma launched a saliva-based Omicron detecting PCR test in Africa. This test is CE marked and can detect all known variants of SARS-Cov-2, including Omicron.
In December 2021, Angstorm Biotech Launched Angcard- India’s first COVID-19 Saliva- Based Home testing kit that allows users to test themselves from the comfort and safety of their homes.
In September 2021, Thermofisher Scientific launched the SpeciMax Stabilized saliva collection kit which is designed to safely collect saliva for research. This kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses.
In March 2021, Salimetrics SalivaLab launched Saliva testing with industry-leading SARS-COV-2 IgG antibody multiplex assay in vaccine clinical trials. This effort provided an unparalleled opportunity for three SARS-COV-2 antigens in the same, easy-to-collect sample.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing infectious diseases among the population
4.2.2 Rising application of Non- invasive Saliva testing as a replacement of Blood testing
4.3 Market Restraints
4.3.1 High costs of collection devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Site of Collection
5.1.1 Parotid Gland Collection
5.1.2 Submandibular collection
5.1.3 Minor Salivary Glands Collection
5.2 By Application
5.2.1 Diagnostic Laboratories
5.3.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle-East and Africa
5.3.5 South America
188.8.131.52 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific
6.1.2 Neogen Corporation
6.1.4 Sarstedt AG and Co.KG
6.1.5 Autogen Inc
6.1.6 Oasis Diagnostics
6.1.8 Salimetrics, LLC
6.1.9 Takara Bio, Inc
6.1.10 Arcis Bio
6.1.11 Orasure Technologies
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global Saliva Collection and Diagnosis Market market is studied from 2019 - 2027.
What is the growth rate of Global Saliva Collection and Diagnosis Market?
The Global Saliva Collection and Diagnosis Market is growing at a CAGR of 10% over the next 5 years.
Which region has highest growth rate in Global Saliva Collection and Diagnosis Market?
North America is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Saliva Collection and Diagnosis Market?
Asia-Pacific holds highest share in 2021.
Who are the key players in Global Saliva Collection and Diagnosis Market?
ThermoFisher Scientific, Abbott, Neogen Corporation, Sarstedt AG&Co.KG-, Autogen Inc are the major companies operating in Global Saliva Collection and Diagnosis Market.